Hemab Therapeutics Holdings, Inc. logo

Hemab Therapeutics Holdings, Inc. (COAG)

Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
32. 52
+2.58
+8.6172%
$
1.39B Market Cap
- P/E Ratio
- Div Yield
478,279 Volume
- Eps
$ 29.94
Previous Close
Analysts:
Add Transaction
Day Range
30.2 33.5
Year Range
23 55.42
Want to track COAG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Hemab Therapeutics Holdings, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
George Soros
George Soros Soros Fund Management LLC
25,000 $693,000 $745,000 $52,000 7.5%
NM
Nir Messafi Deep Track Capita LLP
3.6M $99.85M $117.34M $17.49M 17.51%
Regan O'Neill
Regan O'Neill Burkehill Global Management LP
75,000 $2.08M $2.23M $156,000 7.5%
Li Peng
Li Peng China Universal Asset Management Co. Ltd.
3,600 $99,792 $107,784 $7,992 8.01%
KJ
Ken Joseph Braidwel LLP
160,000 $4.44M $5.18M $740,000 16.68%
Christopher C. Powers
Christopher C. Powers Farther Finance Advisors, LLC
3 $113.91 $87.61 -$26.3 -23.09%
Raymond Debbane
Raymond Debbane Siren, L.L.C.
2.09M $57.85M $67.86M $10.02M 17.32%